Sievers Eric
Chief Medical Officer at BCAB
- Sold, on record
- $329k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Dec 2, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BCABBioAtla, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BCABPlan not statedAug 26, 2021 2021
Sold 6,883 shares at $39.59 ($272k)
Sievers Eric, Chief Medical Officer
Sold 6.8% of holdings ($4M position)93,766 shares leftFirst sale on recordFiling
- 2 Form 4 sale BCABPlan not statedOct 1, 2021 +36 days
Sold 592 shares at $30.39 ($18k)
Sievers Eric, Chief Medical Officer
Sold 0.6% of holdings ($2.8M position)93,174 shares leftFiling
- 3 Form 4 sale BCABPlan not statedNov 24, 2021 +54 days
Sold 434 shares at $25.27 ($11k)
Sievers Eric, Chief Medical Officer
Sold 0.5% of holdings ($2.4M position)92,740 shares leftFiling
- 4 Form 4 sale BCABPlan not statedNov 29, 2021 +5 days
Sold 110 shares at $23.89 ($3k)
Sievers Eric, Chief Medical Officer
Sold 0.1% of holdings ($2.2M position)92,630 shares left0.2x usual sizeFiling
- 5 Form 4 sale BCABPlan not statedDec 2, 2021 +3 days
Sold 1,124 shares at $22.27 ($25k)
Sievers Eric, Chief Medical Officer
Sold 1.2% of holdings ($2.1M position)91,506 shares left2.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Dec 7, 2021 | BCAB | Chief Medical Officer | Form 4 sale | 1,124 | $25k | 1.2% | Plan not stated | SEC |
| Nov 29, 2021 | Dec 6, 2021 | BCAB | Chief Medical Officer | Form 4 sale | 110 | $3k | 0.1% | Plan not stated | SEC |
| Nov 24, 2021 | Nov 30, 2021 | BCAB | Chief Medical Officer | Form 4 sale | 434 | $11k | 0.5% | Plan not stated | SEC |
| Oct 1, 2021 | Oct 7, 2021 | BCAB | Chief Medical Officer | Form 4 sale | 592 | $18k | 0.6% | Plan not stated | SEC |
| Aug 26, 2021 | Aug 30, 2021 | BCAB | Chief Medical Officer | Form 4 sale | 6,883 | $272k | 6.8% | Plan not stated | SEC |